Showing 13–24 of 24 results

Promacta 25 mg Alternative – ETP (Eltrombopag) 25 mg Tablet | Beacon Pharmaceuticals

ETP 25 mg (Eltrombopag) Tablet by Beacon Pharmaceuticals. Reference brand: Promacta. thrombopoietin receptor agonist; used in selected thrombocytopenia and aplastic anemia settings. Prescription medicine. Brand comparison does not establish interchangeability.

Promacta 50 mg Alternative – ETP (Eltrombopag) 50 mg Tablet | Beacon Pharmaceuticals

ETP 50 mg (Eltrombopag) Tablet by Beacon Pharmaceuticals. Reference brand: Promacta. thrombopoietin receptor agonist; used in selected thrombocytopenia and aplastic anemia settings. Prescription medicine. Brand comparison does not establish interchangeability.

Purinethol 50 mg Alternative – Leukin (Mercaptopurine) 50 mg Tablet | Beacon Pharmaceuticals

Leukin 50 mg (Mercaptopurine) Tablet by Beacon Pharmaceuticals. Reference brand: Purinethol. purine antimetabolite; used in selected acute lymphoblastic leukemia regimens. Prescription medicine. Brand comparison does not establish interchangeability.

Revlimid 10 mg Alternative – Linamide (Lenalidomide) 10 mg Capsule | Beacon Pharmaceuticals

Linamide 10 mg (Lenalidomide) Capsule by Beacon Pharmaceuticals. Reference brand: Revlimid. immunomodulatory medicine; used in selected multiple myeloma and myelodysplastic syndrome settings. Prescription medicine. Brand comparison does not establish interchangeability.

Revlimid 25 mg Alternative – Linamide (Lenalidomide) 25 mg Capsule | Beacon Pharmaceuticals

Linamide 25 mg (Lenalidomide) Capsule by Beacon Pharmaceuticals. Reference brand: Revlimid. immunomodulatory medicine; used in selected multiple myeloma and myelodysplastic syndrome settings. Prescription medicine. Brand comparison does not establish interchangeability.

Rituxan / MabThera 100 mg Alternative – Relyto (Rituximab) 100 mg IV infusion | Incepta Pharmaceuticals

Relyto 100 mg (Rituximab) IV infusion is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Rituxan / MabThera (Roche / Genentech).

Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Rituxan / MabThera 500 mg Alternative – Relyto (Rituximab) 500 mg IV infusion | Incepta Pharmaceuticals

Relyto 500 mg (Rituximab) IV infusion is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Rituxan / MabThera (Roche / Genentech).

Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Sprycel 100 mg Alternative – Dasanix (Dasatinib) 100 mg Tablet | Beacon Pharmaceuticals

Dasanix 100 mg (Dasatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Sprycel. BCR-ABL kinase inhibitor; used in selected Philadelphia chromosome-positive leukemias. Prescription medicine. Brand comparison does not establish interchangeability.

Sprycel 20 mg Alternative – Dasanix (Dasatinib) 20 mg Tablet | Beacon Pharmaceuticals

Dasanix 20 mg (Dasatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Sprycel. BCR-ABL kinase inhibitor; used in selected Philadelphia chromosome-positive leukemias. Prescription medicine. Brand comparison does not establish interchangeability.

Venclexta 10 mg Alternative – Venclax (Venetoclax) 10 mg Tablet | Beacon Pharmaceuticals

Venclax 10 mg (Venetoclax) Tablet by Beacon Pharmaceuticals. Reference brand: Venclexta. BCL-2 inhibitor; used in selected chronic lymphocytic leukemia and acute myeloid leukemia. Prescription medicine. Brand comparison does not establish interchangeability.

Venclexta 100 mg Alternative – Venclax (Venetoclax) 100 mg Tablet | Beacon Pharmaceuticals

Venclax 100 mg (Venetoclax) Tablet by Beacon Pharmaceuticals. Reference brand: Venclexta. BCL-2 inhibitor; used in selected chronic lymphocytic leukemia and acute myeloid leukemia. Prescription medicine. Brand comparison does not establish interchangeability.

Vizimpro 45 mg Alternative – Dacocent (Dacomitinib) 45 mg Tablet | Incepta Pharmaceuticals

Dacocent 45 mg (Dacomitinib) by Incepta Pharmaceuticals. EGFR inhibitor for selected EGFR-mutated NSCLC. Reference brand: Vizimpro (Pfizer). Pack: 10 tablets. Prescription only; equivalence not established.